Application of Diffusion Kurtosis Imaging in Evaluating Acute Xerostomia in Nasopharyngeal Carcinoma Treated With Induction Chemotherapy Plus Concurrent Chemoradiotherapy
- PMID: 35664750
- PMCID: PMC9162117
- DOI: 10.3389/fonc.2022.870315
Application of Diffusion Kurtosis Imaging in Evaluating Acute Xerostomia in Nasopharyngeal Carcinoma Treated With Induction Chemotherapy Plus Concurrent Chemoradiotherapy
Abstract
Purpose: The aim of this study was to identify the efficacy of diffusion kurtosis imaging (DKI) in tracking and monitoring the dynamic change of parotid glands (PGs), submandibular glands (SMGs), sublingual glands (SLGs), and acute xerostomia in nasopharyngeal carcinoma (NPC) patients treated with induction chemotherapy (IC) plus concurrent chemoradiotherapy (CCRT).
Methods: The prospective study recruited 42 participants treated with IC+CCRT. All patients underwent DKI scanning six times: before IC, before RT, in the middle of the RT course, immediately after RT, and 1 and 3 months post-RT. Mean diffusion coefficient (MD) and mean kurtosis (MK) of PG, SMG, SLG, saliva flow rate measured under resting (uSFR) and stimulated condition (sSFR), and xerostomia questionnaire (XQ) scores were recorded.
Results: At each time point, sSFR was significantly higher than uSFR (p < 0.05 for all). MD of the salivary glands and XQ scores increased over time while MK, uSFR, and sSFR decreased. After IC, the significant differences were detected in MD and MK of bilateral SMG and MK of the left SLG (p < 0.05 for all), but not in MD and MK of PG, uSFR, sSFR, and XQ scores. After RT, sSFR at 1m-RT decreased significantly (p = 0.03) while no significant differences were detected in uSFR and XQ scores. Moderate-strong correlations were detected in ΔMD-PG-R%, ΔMK-PG-R%, ΔMD-PG-L%, ΔMK-PG-L%, ΔMD-SMG-R%, ΔMK-SMG-R%, ΔMD-SMG-L%, ΔMK-SMG-L%, and ΔMD-SLG-R%, with correlation coefficients (p < 0.05 for all) ranging from 0.401 to 0.714. ΔuSFR% was correlated with ΔMD-SMG% (p = 0.01, r = -0.39), ΔMD-SLG% (p < 0.001, r = -0.532), and ΔMK-SMG% (p < 0.001, r = -0.493). ΔsSFR% correlated with ΔMD-PG% (p = 0.001, r = -0.509), ΔMD-SMG% (p = 0.015, r = -0.221), and ΔMK-PG% (p < 0.001, r = 0.524). ΔXQ% was only correlated with ΔMK-PG% (p = 0.004, r = 0.433).
Conclusion: DKI is a promising tool for tracking and monitoring the acute damage of PG, SMG, and SLG induced by IC+CCRT in NPC patients.
Keywords: diffusion kurtosis imaging; parotid gland; radiation; sublingual gland; submandibular gland; xerostomia.
Copyright © 2022 Zhao, Fang, Zhou, Luo, Wei, Liu, Meng, Liu, Li, Zang, Li, Qiang, Jiang, Fan, Zhang and Ma.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures






Similar articles
-
Sparing submandibular gland to alleviating acute xerostomia in patients with nasopharyngeal carcinoma treated with helical tomotherapy: Evaluation by diffusion kurtosis imaging.Radiother Oncol. 2022 Jul;172:91-98. doi: 10.1016/j.radonc.2022.05.011. Epub 2022 May 15. Radiother Oncol. 2022. PMID: 35584742
-
The impact of submandibular glands protection on xerostomia as monitored by diffusion-weighted imaging in nasopharyngeal carcinoma patients.Strahlenther Onkol. 2024 May;200(5):377-388. doi: 10.1007/s00066-023-02167-6. Epub 2023 Nov 13. Strahlenther Onkol. 2024. PMID: 37955647
-
Diffusion-weighted imaging as a follow-up modality for evaluation of major salivary gland function in nasopharyngeal carcinoma patients: a preliminary study.Strahlenther Onkol. 2020 Jun;196(6):530-541. doi: 10.1007/s00066-020-01580-5. Epub 2020 Feb 5. Strahlenther Onkol. 2020. PMID: 32025803 Free PMC article. Clinical Trial.
-
Reducing xerostomia after chemo-IMRT for head-and-neck cancer: beyond sparing the parotid glands.Int J Radiat Oncol Biol Phys. 2012 Jul 1;83(3):1007-14. doi: 10.1016/j.ijrobp.2011.09.004. Epub 2011 Nov 4. Int J Radiat Oncol Biol Phys. 2012. PMID: 22056067 Free PMC article.
-
Diffusion weighted imaging in submandibular gland sparing helical tomotherapy for nasopharyngeal carcinoma.Radiother Oncol. 2021 Apr;157:247-254. doi: 10.1016/j.radonc.2021.02.004. Epub 2021 Feb 13. Radiother Oncol. 2021. PMID: 33587972
References
-
- Yang H, Chen X, Lin S, Rong J, Yang M, Wen Q, et al. . Treatment Outcomes After Reduction of the Target Volume of Intensity-Modulated Radiotherapy Following Induction Chemotherapy in Patients With Locoregionally Advanced Nasopharyngeal Carcinoma: A Prospective, Multi-Center, Randomized Clinical Trial. Radiother Oncol (2018) 126(1):37–42. doi: 10.1016/j.radonc.2017.07.020 - DOI - PubMed
-
- Liu LT, Chen QY, Tang LQ, Guo SS, Guo L, Mo HY, et al. . Neoadjuvant or Adjuvant Chemotherapy Plus Concurrent CRT Versus Concurrent CRT Alone in the Treatment of Nasopharyngeal Carcinoma: A Study Based on EBV DNA. J Natl Compr Canc Netw (2019) 17(6):703–10. doi: 10.6004/jnccn.2018.7270 - DOI - PubMed
-
- Kong L, Zhang Y, Hu C, Guo Y, Lu JJ. Effects of Induction Docetaxel, Platinum, and Fluorouracil Chemotherapy in Patients With Stage III or IVA/B Nasopharyngeal Cancer Treated With Concurrent Chemoradiation Therapy: Final Results of 2 Parallel Phase 2 Clinical Trials. Cancer (2017) 123(12):2258–67. doi: 10.1002/cncr.30566 - DOI - PubMed
LinkOut - more resources
Full Text Sources